Safety and Effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial

Peer Review reports

Original Submission
6 Jul 2011	Submitted	Original manuscript
7 Aug 2011	Reviewed	Reviewer Report - Fernando Martinez-Sagasti
24 Aug 2011	Author responded	Author comments - JOSE LUIS IRIBARREN
Resubmission - Version 2
24 Aug 2011	Submitted	Manuscript version 2
Publishing
14 Oct 2011	Editorially accepted
14 Oct 2011	Article published	10.1186/1749-8090-6-138

Back to article page